Investing.comCodex · 实盘不做把握 5/10不做原因:风险收益比不佳
北京时间·🕒 发布 08-25 22:04:29·⟳ 抓取 08-25 22:09:13 +4m44s·⚡ 决策 08-26 02:35:55 +4h26m·62.6 天前
Leidos获美国海军健康研究中心5600万美元行为健康研究合同
合同真实且方向正面，但金额相对Leidos收入和市值过小，难以形成足够短线预期差；同时当前会话没有可用stock_tools完成真实报价、去重、案例库和event_study校验，不能合规给出ENTER。
📄 原文Investing.com↗ 原文
Leidos wins $56M Navy contract for military health research
Wall Street opens higher amid falling oil prices and Treasury yields RESTON, Va. - Leidos (NYSE:LDOS) announced today i…
不做 Leidos Holdings（LDOS.US）
不做Leidos Holdings（LDOS.US）：订单属正面但年化收入贡献约0.06%，对大市值政府承包商短线重估弹性不足，且本会话无法调用真实行情与event_study完成ENTER前校验。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Leidos官网确认其获得NHRC 5600万美元、66个月合同，属于正面订单信息；但公司FY2025收入约171.74亿美元，该合同总额仅约0.33%收入、年化约1018万美元仅约0.06%收入，对170亿美元级收入和约180亿美元市值公司的短线业绩弹性有限，Investing.com为公司稿转述且非独家重大增量，因此不做。
消息传播链
- 公司官网发布本次NHRC合同新闻，披露5600万美元总值和66个月履约期。
- Investing.com转述公司新闻，未提供超出公司稿的重大新增金额或条款。
关键理由
- 合同由Leidos官网确认，客户为美国海军健康研究中心，业务方向与公司政府服务能力匹配。
- 量级句：FY2025收入约171.74亿美元，本次5600万美元合同分66个月确认，年化约1018万美元，仅约占收入0.06%、总额约占收入0.33%，对利润和市值弹性很小。
主要风险
- 未能调用真实stock_quote确认LDOS.US在事件后价格、成交量和是否已有同向重定价，因此不能给可执行入场价。
- 小额政府合同可能已属于日常订单流，市场通常不会为单笔低收入占比合同显著重估。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-08-25 · 影响 weakens
反向约束是量级不足：合同总额仅5600万美元且跨66个月确认，年化收入贡献很小。
检索:Leidos $56 million Navy contract annual revenue materiality LDOS 原文 ↗ - 做多前查反向 · 来源 web · 日期 2026-02-17 · 影响 weakens
SEC 10-K显示公司FY2025收入171.74亿美元，本合同对收入基数影响有限。
检索:Leidos annual revenue fiscal 2025 17.2 billion SEC 10-K 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例证据不足与量级偏小共同支持AVOID，不给条件单。
方向:未能在本会话完成event_study；从公开事实看，小额政府服务合同方向正面但通常不足以单独驱动大市值承包商重估。
涨幅量级:缺少可用event_study结果，不能用历史样本校准tp/sl；金额占比本身显示幅度上限有限。
形态:未完成系统要求的历史事件定量研究，不用先例支持交易。
原文全文
展开原文 · 1,564 字
Wall Street opens higher amid falling oil prices and Treasury yields
RESTON, Va. - Leidos (NYSE:LDOS) announced today it received a contract from the Naval Health Research Center to conduct behavioral health research and operational assessments for U.S. military personnel.
The contract has a total value of $56 million over a 66-month period, according to a press release statement. The work will focus on identifying risks and protective measures affecting the health, performance and readiness of military personnel throughout the deployment cycle.
Leidos will provide data-driven analyses and help translate scientific findings into solutions aimed at improving force readiness. The company will support research on psychological factors that impact military populations.
"This program reinforces the need for mission-critical health research in the military community," said Sarah McNichol, vice president of Behavioral Health & Readiness at Leidos Health.
The Naval Health Research Center is one of eight laboratories within the Navy Medical Research & Development Enterprise. The center focuses on optimizing operational readiness and health of U.S. armed forces through behavioral health, epidemiology, readiness, and disease surveillance.
Leidos is headquartered in Reston, Virginia, and employs approximately 50,000 people globally. The company reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
RESTON, Va. - Leidos (NYSE:LDOS) announced today it received a contract from the Naval Health Research Center to conduct behavioral health research and operational assessments for U.S. military personnel.
The contract has a total value of $56 million over a 66-month period, according to a press release statement. The work will focus on identifying risks and protective measures affecting the health, performance and readiness of military personnel throughout the deployment cycle.
Leidos will provide data-driven analyses and help translate scientific findings into solutions aimed at improving force readiness. The company will support research on psychological factors that impact military populations.
"This program reinforces the need for mission-critical health research in the military community," said Sarah McNichol, vice president of Behavioral Health & Readiness at Leidos Health.
The Naval Health Research Center is one of eight laboratories within the Navy Medical Research & Development Enterprise. The center focuses on optimizing operational readiness and health of U.S. armed forces through behavioral health, epidemiology, readiness, and disease surveillance.
Leidos is headquartered in Reston, Virginia, and employs approximately 50,000 people globally. The company reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。